| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cardioprotection in the Clinical Setting
|
Ivanes, Fabrice
|
|
2010
|
24 |
3 |
p. 281-287
|
article
|
| 2 |
Cardioprotection in the Clinical Setting-Lessons from J-WIND Studies
|
Asakura, Masanori
|
|
2010
|
24 |
3 |
p. 289-295
|
article
|
| 3 |
How to Mediate Cardioprotection in Ischemic Hearts—Accumulated Evidence of Basic Research Should Translate to Clinical Medicine
|
Kitakaze, Masafumi
|
|
2010
|
24 |
3 |
p. 217-223
|
article
|
| 4 |
Mechanism of Cardioprotection by Early Ischemic Preconditioning
|
Yang, Xiulan
|
|
2010
|
24 |
3 |
p. 225-234
|
article
|
| 5 |
Mitochondria and GSK-3β in Cardioprotection Against Ischemia/Reperfusion Injury
|
Miura, Tetsuji
|
|
2010
|
24 |
3 |
p. 255-263
|
article
|
| 6 |
Neonatal Exendin-4 Leads to Protection from Reperfusion Injury and Reduced Rates of Oxidative Phosphorylation in the Adult Rat Heart
|
Brown, Suzanne B.
|
|
2010
|
24 |
3 |
p. 197-205
|
article
|
| 7 |
Postconditioning in Reperfusion Injury: A Status Report
|
Zhao, Zhi-Qing
|
|
2010
|
24 |
3 |
p. 265-279
|
article
|
| 8 |
Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly Contribute to the Prevention of In-stent Restenosis
|
Yan, Ying
|
|
2010
|
24 |
3 |
p. 189-195
|
article
|
| 9 |
Role of Dual Antiplatelet Therapy in Symptomatic Patients with Established Vascular Disease: Putting the CHARISMA Trial into Therapeutic Perspective
|
Boden, William E.
|
|
2010
|
24 |
3 |
p. 207-216
|
article
|
| 10 |
The Second Window of Preconditioning (SWOP) Where Are We Now?
|
Hausenloy, Derek J.
|
|
2010
|
24 |
3 |
p. 235-254
|
article
|
Journal description